Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial
Titel:
Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial
Auteur:
Zhang, Yi-Chen Chen, Zhi-Hong Zhang, Xu-Chao Xu, Chong-Rui Yan, Hong-Hong Xie, Zhi Chuai, Shao-Kun Ye, Jun-Yi Han-Zhang, Han Zhang, Zhou Bai, Xiao-Yan Su, Jian Gan, Bin Yang, Jin-Ji Li, Wen-Feng Tang, Wei Luo, Feng Roger Xu, Xiao Wu, Yi-Long Zhou, Qing